Please Note: This trial is no longer enrolling new participants
Phase I/II Study of Stereotactic Radiosurgery with Concurrent Administration of DNA Damage Response (DDR) Inhibitor (OLAparib) Followed by Adjuvant Combination of DuRvalumab (MEDI4736) and Physician s Choice Systemic Therapy in Subjects with BreAst Cancer Brain Metastases (SOLARA)
| Protocol No. | CTO-BRE18-360 | Scope | National |
|---|---|---|---|
| Principal Investigator | Kathy Miller | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase I/II |
